HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiaoling Lu Selected Research

Proteins (Proteins, Gene)

11/2023Nanobody-based trispecific T cell engager (Nb-TriTE) enhances therapeutic efficacy by overcoming tumor-mediated immunosuppression.
1/2023Identification of novel key genes associated with uterine corpus endometrial carcinoma progression and prognosis.
12/2022Nanobody-based CAR T cells targeting intracellular tumor antigens.
1/2022Dendritic cells modified by tumor associated antigen SMP30 have enhanced antitumor effect against mouse hepatocarcinoma cells in vitro and in vivo.
8/2021A Single-Chain Variable Fragment Antibody/Chemokine Fusion Protein Targeting Human Endoglin to Enhance the Anti-Tumor Activity of Cytokine-Induced Killer Cells.
7/2020Recombinant Endoglin-Single-Chain Variable Fragment/ Induced Protein 10 Fusion Protein Potently Boosts the Anti-Tumor Efficacy of Adoptively Transferred TRP2-Specific CD8+ CD28+ Cytotoxic T Lymphocytes in Mice.
1/2019Opportunities and Challenges for Antibodies against Intracellular Antigens.
1/2017Isolation of Fibroblast-Activation Protein-Specific Cancer-Associated Fibroblasts.
12/2016Senescence marker protein 30 (SMP30) serves as a potential prognostic indicator in hepatocellular carcinoma.
11/2016Enhanced anti-tumor immunity against breast cancer induced by whole tumor cell vaccines genetically modified expressing α-Gal epitopes.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiaoling Lu Research Topics

Disease

51Neoplasms (Cancer)
01/2024 - 12/2006
11Hepatocellular Carcinoma (Hepatoma)
01/2022 - 12/2014
8Breast Neoplasms (Breast Cancer)
10/2022 - 01/2014
7Neoplasm Metastasis (Metastasis)
12/2022 - 01/2014
5Melanoma (Melanoma, Malignant)
07/2020 - 11/2008
3Infections
02/2024 - 12/2017
3Ototoxicity
01/2024 - 10/2020
3Carcinogenesis
01/2022 - 08/2014
3Leukemia
05/2018 - 08/2016
3Glioma (Gliomas)
10/2010 - 09/2007
2Lung Neoplasms (Lung Cancer)
12/2021 - 11/2021
2Liver Neoplasms (Liver Cancer)
01/2020 - 01/2017
2Experimental Melanoma
01/2018 - 01/2017
2Hypoxia (Hypoxemia)
07/2017 - 01/2015
2Tuberculosis (Tuberculoses)
10/2016 - 02/2016
2Inflammation (Inflammations)
01/2015 - 03/2013
1Spontaneous Abortion (Miscarriage)
12/2023
1Bites and Stings (Sting)
11/2023
1Hearing Loss (Hearing Impairment)
01/2023
1Wilms Tumor (Wilm's Tumor)
12/2022
1Chronic Obstructive Pulmonary Disease (COPD)
12/2022
1Obstructive Sleep Apnea
10/2022
1Noise-Induced Hearing Loss (Acoustic Trauma)
09/2022
1Tinnitus
01/2022
1Esophageal Squamous Cell Carcinoma
01/2022
1Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
11/2021
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2021

Drug/Important Bio-Agent (IBA)

11Proteins (Proteins, Gene)FDA Link
11/2023 - 11/2014
8Peptides (Polypeptides)IBA
12/2022 - 12/2006
7VaccinesIBA
01/2023 - 11/2016
6Neoplasm Antigens (Tumor Antigens)IBA
11/2023 - 10/2010
6AntigensIBA
01/2023 - 01/2018
6CytokinesIBA
01/2023 - 05/2013
6Monoclonal AntibodiesIBA
12/2021 - 02/2018
6Liposomes (Liposome)IBA
01/2021 - 08/2013
6EpitopesIBA
01/2019 - 09/2007
5Single-Domain AntibodiesIBA
11/2023 - 05/2016
5Biomarkers (Surrogate Marker)IBA
12/2021 - 11/2014
5EndoglinIBA
08/2021 - 01/2019
4Cisplatin (Platino)FDA LinkGeneric
01/2024 - 10/2018
4Chimeric Antigen ReceptorsIBA
01/2023 - 01/2020
4InterferonsIBA
07/2020 - 08/2013
4Folic Acid (Vitamin M)FDA LinkGeneric
01/2017 - 12/2014
4ChitosanIBA
01/2017 - 12/2014
3Interleukin-2 (IL2)IBA
01/2022 - 10/2016
3Single-Chain AntibodiesIBA
08/2021 - 11/2013
3Silicon Dioxide (Silica)FDA LinkGeneric
01/2020 - 12/2016
3CateninsIBA
08/2018 - 03/2013
3HLA-A2 Antigen (HLA A2 Antigen)IBA
10/2010 - 12/2006
2DNA (Deoxyribonucleic Acid)IBA
01/2024 - 08/2013
2RNA (Ribonucleic Acid)IBA
01/2023 - 08/2017
2ChemokinesIBA
08/2021 - 04/2016
2DiterpenesIBA
01/2021 - 01/2014
2APTIBA
01/2021 - 01/2019
2Antineoplastic Agents (Antineoplastics)IBA
01/2021 - 08/2014
2CPG-oligonucleotideIBA
05/2019 - 01/2018
2Mannose (D-Mannose)IBA
05/2019 - 01/2018
2AntibodiesIBA
01/2019 - 02/2018
2Glycoproteins (Glycoprotein)IBA
08/2018 - 05/2013
2Therapeutic UsesIBA
05/2018 - 01/2017
2SaltsIBA
07/2017 - 05/2016
2HLA Antigens (Human Leukocyte Antigens)IBA
10/2010 - 09/2007
2Interleukin-13 Receptors (Interleukin 13 Receptor)IBA
12/2007 - 09/2007
1ProdigiosinIBA
02/2024
1formononetinIBA
01/2024
110-hydroxycamptothecinIBA
01/2024
1homocamptothecinIBA
01/2024
1N(1)-methyl-2-lysergic acid diethylamide (MIL)IBA
01/2024
1IonsIBA
01/2024
1IronIBA
01/2024
1mono-(2-ethylhexyl)phthalateIBA
12/2023
1Matrix Metalloproteinases (MMPs)IBA
12/2023
1phenyl-2-aminoethyl sulfide (PAES)IBA
12/2023
1Purinergic P2X7 ReceptorsIBA
01/2023
1epidermal growth factor receptor VIIIIBA
01/2023
1AminoglycosidesIBA
01/2023
1Anti-Bacterial Agents (Antibiotics)IBA
01/2023
1Oxygen (Dioxygen)IBA
12/2022
1Oncogene Proteins (Oncogene Protein)IBA
12/2022
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
12/2022
1GlypicansIBA
12/2022
1Surface Antigens (Surface Antigen)IBA
12/2022
1LipidsIBA
10/2022
1rebeccamycinIBA
10/2022
1Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)IBA
09/2022
1lly-283IBA
09/2022
1nedaplatinIBA
01/2022
1Mechanistic Target of Rapamycin Complex 1IBA
01/2022
1Interferon-gamma (Interferon, gamma)IBA
08/2021
1ThioredoxinsIBA
01/2021
1libertellenone HIBA
01/2021
1pimaraneIBA
01/2021

Therapy/Procedure

17Therapeutics
01/2024 - 11/2013
15Immunotherapy
12/2022 - 09/2007
5Drug Therapy (Chemotherapy)
01/2024 - 12/2016
3Radiotherapy
12/2022 - 01/2016
1Continuous Positive Airway Pressure
10/2022
1Chemoradiotherapy
01/2022
1Electrodes (Electrode)
01/2022
1Cell- and Tissue-Based Therapy (Cell Therapy)
01/2021